Twist Bioscience Corporation (TWST) stock analysis

In our weekly check, Twist Bioscience Corporation is graded D (A to F). Of 21 checks on debt, profit, cash flow and trend: 11 pass, warnings: 1, red flags: 9.

About Twist Bioscience Corporation

Twist Bioscience Corporation is a Healthcare company (Diagnostics & Research) based in the United States, listed on NASDAQ as TWST.

What our checks show for TWST

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-01

Similar companies

AXSM · ORKA · IMVT · TXG · ABVX · KOD

Questions

What grade does Twist Bioscience Corporation (TWST) have?

In our weekly check, Twist Bioscience Corporation is graded D (A to F). Of 21 checks on debt, profit, cash flow and trend: 11 pass, warnings: 1, red flags: 9. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of TWST stock?

This week's biggest flags for Twist Bioscience Corporation: Weak EPS forecast, Weak EPS growth, Thin margins. In total 10 of 21 checks show a warning or a red flag.

What does Twist Bioscience Corporation do?

Twist Bioscience Corporation is a Healthcare company (Diagnostics & Research) based in the United States, listed on NASDAQ as TWST.

When does Twist Bioscience Corporation report earnings next?

The next earnings report is expected on 2027-02-01. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis